Peptone
- Biotech or pharma, therapeutic R&D
Peptone is a biotechnology company developing novel first-in-class small molecule therapeutics targeting intrinsically disordered proteins (IDPs) to treat diseases through a pioneering experimental approach that starts with studying the structural dynamics of IDPs. Peptone's technology accurately translates bespoke experimental data into dynamic models of disordered proteins regardless of protein size or complexity with the necessary speed and insights to design therapeutics capable of affecting IDP function. The company's initial focus is on oncology targets areas of highly unmet need with strong disease hypotheses and biological validation. For more information about Peptone, visit https://peptone.io.